EHC Stock Analysis: Buy, Sell, or Hold?
EHC - Encompass Health Corporation Common Stock
$120.31
-0.60 (-0.50%)
âŧ
5d:
-2.65%
30d:
+8.33%
90d:
+15.18%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When EHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: EHC is fairly priced but lacks strong directional signals. At 2.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: EHC is fairly priced but lacks strong directional signals. At 2.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$154.32
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$95.82
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EHC is currently trading at $120.31, which is considered slightly high relative to its 30-day fair value range of $110.75 to $122.54. The stock's valuation (Forward PE: 18.0) is in line with its historical norms (16.8). At these levels, the market is pricing in 2.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EHC is in a strong uptrend. The price is currently testing key support at $120.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EHC scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $148.17 (+23.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EHC is in a strong uptrend. The price is currently testing key support at $120.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EHC scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $148.17 (+23.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$110.75 -
$122.54
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
43.8%
All Signals
- BEARISH: Weak technical setup (19/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.2% below Wall St target ($148.17)
- NEUTRAL: Market pricing in 2.4% annual earnings growth - fairly valued
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$110.75 -
$122.54
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$120.10
Resistance Level
$127.50
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.02
Wall Street Target
$148.17
(+23.2%)
Revenue Growth (YoY)
9.6%
Earnings Growth (YoY)
10.8%
Profit Margin
10.0%
Valuation Premium vs History
+2.4% premium
PE vs Historical
18.0 vs 16.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.4%
(market-implied from PE analysis)
1-Year Target
$123.20
(+2%)
2-Year Target
$126.15
(+5%)
3-Year Target
$129.18
(+7%)
3-Yr Target (if PE normalizes)
(PE: 18â17)
PE COMPRESSION
$120.46
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 9.2%)
$174.71
(+45%)
Base:
(SPY PE: 18.0, Growth: 9.2%)
$156.83
(+30%)
Bear:
(PE: 15.3, Growth: 9.2%)
$133.31
(+11%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 20.19 | Current EPS (TTM): $5.99
Bull Case
$148.28
(+23%)
Analyst growth 11.5%, PE expands to 22.2
Base Case
$134.80
(+12%)
Market implied 11.5%, PE stable at 20.2
Bear Case
$82.22
(-32%)
Severe decline -20.0%, PE contracts to 17.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 6:27 PM ET
Data refreshes hourly during market hours. Next update: 7:27 PM
Data refreshes hourly during market hours. Next update: 7:27 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Edmund Fay
SELL
11937 shares
2026-03-09
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$455 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
|
SGRY
Surgery Partners Inc |
STRONG BUY
12 analysts |
$19 | 58 HOLD |
